Predictmedix Inc.
PMEDF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | 0% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | 76% | 76% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $2 | $2 |
| SG&A Expenses | $1 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $1 | $2 | $2 | $2 |
| Operating Income | -$1 | -$2 | -$2 | -$2 |
| % Margin | – | – | -5,896.3% | -4,718.3% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$2 | -$2 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$2 | -$2 | -$2 |
| % Margin | – | – | -5,904.5% | -5,374.6% |
| EPS | -0.008 | -0.014 | -0.018 | -0.017 |
| % Growth | 43.9% | 23.2% | -4% | – |
| EPS Diluted | -0.008 | -0.014 | -0.018 | -0.017 |
| Weighted Avg Shares Out | 150 | 143 | 114 | 108 |
| Weighted Avg Shares Out Dil | 150 | 143 | 114 | 108 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$2 | -$2 | -$2 |
| % Margin | – | – | -5,441% | -5,148.2% |